Melmed S, Pituitary-Tumor, Endocrinopathies (2020) N Engl J Med 382(10):937–950. https://doi.org/10.1056/NEJMra1810772

Colao A, Grasso LFS, Giustina A et al (2019) Acromegaly. Nat Rev Dis Primers 5(1):20. https://doi.org/10.1038/s41572-019-0071-6

Article  PubMed  Google Scholar 

Melmed S, Kaiser UB, Lopes MB et al (2022) Clinical Biology of the Pituitary Adenoma. Endocr Rev 43(6):1003–1037. https://doi.org/10.1210/endrev/bnac010

Article  PubMed  PubMed Central  Google Scholar 

Giustina A, Boni E, Romanelli G, Grossi V, Giustina G (1995) Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide. Am J Cardiol 75(15):1042–1047. https://doi.org/10.1016/S0002-9149(99)80721-8

Article  CAS  PubMed  Google Scholar 

Giustina A, Barkan A, Beckers A et al (2020) A Consensus on the diagnosis and treatment of Acromegaly comorbidities: an update. J Clin Endocrinol Metab 105(4):e937–e946. https://doi.org/10.1210/clinem/dgz096

Article  Google Scholar 

Arosio M, Sciannameo V, Contarino A et al (2024) Disease control of acromegaly does not prevent excess mortality in the long term: results of a nationwide survey in Italy. J Endocrinol Invest Published Online January 12. https://doi.org/10.1007/s40618-023-02257-3

Orme S, McNally R, James PW et al (2024) Increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of GH levels—A retrospective analysis from the UK Acromegaly Register 1970–2016. Published Online April 23 Clin Endocrinol (Oxf). https://doi.org/10.1111/cen.15060

Giustina A, Biermasz N, Casanueva FF et al (2024) Consensus on criteria for acromegaly diagnosis and remission. Pituitary 27(1):7–22. https://doi.org/10.1007/s11102-023-01360-1

Article  CAS  PubMed  Google Scholar 

Giustina A, Barkhoudarian G, Beckers A et al (2020) Multidisciplinary management of acromegaly: a consensus. Rev Endocr Metab Disord 21(4):667–678. https://doi.org/10.1007/s11154-020-09588-z

Article  PubMed  PubMed Central  Google Scholar 

Casanueva FF, Barkan AL, Buchfelder M et al (2017) Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): a Pituitary Society Statement. Pituitary 20(5):489–498. https://doi.org/10.1007/s11102-017-0838-2

Article  PubMed  PubMed Central  Google Scholar 

Giustina A, Uygur MM, Frara S et al (2023) Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers. Pituitary 26(5):583–596. https://doi.org/10.1007/s11102-023-01345-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giustina A, Uygur MM, Frara S et al (2024) Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE). Pituit Published Online June 4. https://doi.org/10.1007/s11102-024-01397-w

Giustina A, Bronstein MD, Chanson P et al (2019) Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT® validation study. Pituitary 22(5):476–487. https://doi.org/10.1007/s11102-019-00977-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giustina A, di Filippo L, Uygur MM, Frara S (2023) Modern approach to resistant acromegaly. Endocrine 80(2):303–307. https://doi.org/10.1007/s12020-023-03317-7

Article  CAS  PubMed  Google Scholar 

Chiloiro S, Moroni R, Giampietro A et al (2023) The Multibiomarker Acro-TIME score predicts fg-SRLs response: preliminary results of a retrospective acromegaly cohort. J Clin Endocrinol Metab Published Online November 17. https://doi.org/10.1210/clinem/dgad673

Chiloiro S, Bianchi A, Giampietro A, Pontecorvi A, Raverot G, Marinis L, De (2022) Second line treatment of acromegaly: Pasireotide or Pegvisomant? Best Pract Res Clin Endocrinol Metab. https://doi.org/10.1016/j.beem.2022.101684

Gadelha MR, Wildemberg LE, Kasuki L (2022) The future of somatostatin receptor ligands in Acromegaly. J Clin Endocrinol Metab 107(2):297–308. https://doi.org/10.1210/clinem/dgab726

Article  PubMed  Google Scholar 

Giustina A, Chanson P, Kleinberg D et al (2014) Expert consensus document: a consensus on the medical treatment of acromegaly. Nat Rev Endocrinol 10(4):243–248. https://doi.org/10.1038/nrendo.2014.21

Article  CAS  PubMed  Google Scholar 

Brunetti A, Antonini S, Saladino A, Lavezzi E, Zampetti B, Cozzi R (2022) Clinical Management of Acromegaly: therapeutic frontiers and new perspectives for somatostatin receptor ligands (SRLs). Med (B Aires) 58(6):794. https://doi.org/10.3390/medicina58060794

Article  Google Scholar 

Marques-Pamies M, Gil J, Jordà M, Puig-Domingo M (2023) Predictors of response to treatment with first-generation somatostatin receptor ligands in patients with acromegaly. Arch Med Res 54(8):102924. https://doi.org/10.1016/j.arcmed.2023.102924

Article  CAS  PubMed  Google Scholar 

Remba-Shapiro I, Nachtigall LB Treatment of acromegaly with oral octreotide. Best Pract Res Clin Endocrinol Metab Published Online Febr 2024:101888. https://doi.org/10.1016/j.beem.2024.101888

Samson SL, Nachtigall LB, Fleseriu M et al (2022) Durable biochemical response and safety with oral octreotide capsules in acromegaly. Eur J Endocrinol 187(6):733–741. https://doi.org/10.1530/EJE-22-0220

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samson SL, Nachtigall LB, Fleseriu M et al (2020) Maintenance of Acromegaly Control in patients switching from Injectable somatostatin receptor ligands to oral Octreotide. J Clin Endocrinol Metab 105(10):e3785–e3797. https://doi.org/10.1210/clinem/dgaa526

Article  PubMed  PubMed Central  Google Scholar 

Gola M, Bonadonna S, Mazziotti G, Amato G, Giustina A (2006) Resistance to somatostatin analogs in acromegaly: an evolving concept? J Endocrinol Invest 29(1):86–93. https://doi.org/10.1007/BF03349183

Article  CAS  PubMed  Google Scholar 

Kasuki L, Lamback E, Antunes X, Gadelha MR (2024) Biomarkers of response to treatment in acromegaly. Expert Rev Endocrinol Metab 19(1):71–80. https://doi.org/10.1080/17446651.2023.2293107

Article  CAS  PubMed  Google Scholar 

Giustina A, Bonadonna S, Bugari G et al (2009) High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. Eur J Endocrinol 161(2):331–338. https://doi.org/10.1530/EJE-09-0372

Article  CAS  PubMed  Google Scholar 

Giustina A, Mazziotti G, Cannavò S et al (2017) High-dose and High-Frequency Lanreotide Autogel in Acromegaly: a Randomized, Multicenter Study. J Clin Endocrinol Metab 102(7):2454–2464. https://doi.org/10.1210/jc.2017-00142

Article  PubMed  Google Scholar 

Frara S, Maffezzoni F, Mazziotti G, Giustina A (2016) The Modern Criteria for Medical Management of Acromegaly. Prog Mol Biol Transl Sci 138:63–83. https://doi.org/10.1016/bs.pmbts.2015.10.015

Article  PubMed  Google Scholar 

Serioli S, Doglietto F, Fiorindi A et al (2019) Pituitary adenomas and invasiveness from Anatomo-Surgical, Radiological, and histological perspectives: a systematic literature review. Cancers (Basel) 11(12):1936. https://doi.org/10.3390/cancers11121936

Article  CAS  PubMed  Google Scholar 

Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary Adenomas with Invasion of the cavernous Sinus Space. Neurosurgery 33(4):610–618. https://doi.org/10.1227/00006123-199310000-00008

Article  CAS  PubMed  Google Scholar 

Chiloiro S, Bianchi A, Doglietto F et al (2014) Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review. Pituitary 17(3):267–276. https://doi.org/10.1007/s11102-013-0500-6

Article  PubMed  Google Scholar 

Coli A, Asa SL, Fadda G et al (2016) Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients. Eur J Endocrinol 174(3):307–314. https://doi.org/10.1530/EJE-15-0586

Article  CAS  PubMed  Google Scholar 

Heck A, Ringstad G, Fougner SL et al (2012) Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly. Clin Endocrinol (Oxf) 77(1):72–78. https://doi.org/10.1111/j.1365-2265.2011.04286.x

Article  CAS  PubMed  Google Scholar 

Ramírez-Rentería C, Hernández-Ramírez LC (2024) Genetic diagnosis in acromegaly and gigantism: from research to clinical practice. Best Pract Res Clin Endocrinol Metab 38(3):101892. https://doi.org/10.1016/j.beem.2024.101892

Article